Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening and economics.

J A Stilwell1

  • 1Health Services Research Unit, Warwick Business School, University of Warwick, UK.

Journal of Inherited Metabolic Disease
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Discounting future benefits in cost-benefit analysis is crucial for disease screening. Societal time preference and capital productivity justify this, alongside valuing human lives for accurate economic assessments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of cost and management information to improve the efficiency of an out patients clinic.

Health services management research·1988
Same author

Information for decision makers at hospital laboratory level: an example of a graphical method of representing costs and effects for a replacement automated technology in a haematology laboratory.

Social science & medicine (1982)·1988
Same author

What do economists measure?

Journal of sterile services management·1987
Same author

Microcomputer software to facilitate costing in pathology laboratories.

Journal of clinical pathology·1987
Same author

Information for managers in hospitals: representing maternity unit statistics graphically.

British medical journal (Clinical research ed.)·1987
Same author

Sickness absence in an ambulance service.

The Journal of the Society of Occupational Medicine·1984
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Gaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.

Journal of inherited metabolic disease·2026
See all related articles

Area of Science:

  • Health economics
  • Public health policy

Background:

  • Disease screening programs require upfront investment for future health benefits.
  • Understanding the rationale for discounting future benefits is essential for accurate cost-benefit analysis.
  • Societal time preference and capital productivity are key economic factors influencing future value.

Purpose of the Study:

  • To elucidate the economic principles behind discounting future benefits in health interventions.
  • To discuss the valuation of human lives within cost-benefit frameworks.
  • To outline a systematic approach for conducting cost-benefit calculations in disease screening.

Main Methods:

  • Economic theory of time preference and capital productivity.
  • Discussion of human life valuation in policy.

Related Experiment Videos

  • Systematic cost-benefit calculation methodology.

    • Main Results:

    • Future benefits are discounted due to present consumption preference and capital's productive capacity.
    • UK immigration policy simplifies life valuation in cost-benefit analysis, equating it to zero or negative net value.
    • Systematic calculation is vital to prevent errors like double counting or omissions.

    Conclusions:

    • Discounting is a fundamental economic concept applicable to disease screening cost-benefit analyses.
    • Accurate cost-benefit calculations require careful consideration of societal preferences and capital productivity.
    • Systematic approaches, such as using spreadsheets, are recommended for reliable economic evaluations in public health.